Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD7325 in Generalized Anxiety Disorder
NCT00808249Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azd7325 in generalized anxiety disorder (GAD), sponsored by AstraZeneca. Started Dec 2008; status: completed.
02
Drugs
azd7325
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00808249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808249.